![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Single-Dose Pharmacokinetics of Daclatasvir (DCV; BMS-790052) in Subjects With Hepatic Impairment Compared With Healthy Subjects
|
|
|
Reported by Jules Levin
AASLD
Nov 5 2011 SF
Bifano M,1 Sevinsky H,1 Persson A,2 Chung E,1 Wind-Rotolo M,2 Hwang C,1 Nettles R,1 Grasela D,1 Marbury T,3 DeMicco M,4 Bertz R1
1Bristol-Myers Squibb, Research and Development, Hopewell, NJ; 2Bristol-Myers Squibb, Research and Development, Lawrenceville, NJ; 3Orlando Clinical Research Center, Orlando, FL; 4Advanced Clinical Research Institute, Anaheim, CA
![AASLD1.gif](../images/111711/111711-3/AASLD1.gif)
![AASLD2.gif](../images/111711/111711-3/AASLD2.gif)
![AASLD3.gif](../images/111711/111711-3/AASLD3.gif)
![AASLD4.gif](../images/111711/111711-3/AASLD4.gif)
![AASLD5.gif](../images/111711/111711-3/AASLD5.gif)
![AASLD6.gif](../images/111711/111711-3/AASLD6.gif)
![AASLD7.gif](../images/111711/111711-3/AASLD7.gif)
![AASLD8.gif](../images/111711/111711-3/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|